Select Language:
EnglishEspañol
Adjust Text Size:
change font sizechange font sizechange font sizechange font sizechange font sizechange font size

Browse Clinical Trials


Join the Email List

Sign up for our email bulletin

Go

Participant Stories

“I feel like there is hope, great hope, more hope now than ever before.” –Peggy Willocks, Diagnosed 14 years

Read More

Recently Diagnosed with Parkinson's Disease?

If you have recently been diagnosed with Parkinson’s disease (PD) understanding the disease, and learning about the resources available to you, are good first steps.

Learn More

News Archive

BrainStorm Aims to be the First Worldwide to Win FDA Approval to Conduct Trials for PD Using Adult Stem Cells

Biopharmaceutical company BrainStorm Cell Therapeutics Ltd. has arranged a first meeting with the US Food and Drug Administration (FDA) to coordinate clinical trials for its flagship product for the treatment of Parkinson's disease. The company said it aims to be the first worldwide to win approval to conduct trials using adult stem cells taken from patients.

BrainStorm has hired Dr. Andra E. Miller, director of cell and gene therapies of the Biologics Consulting Group, Inc. as consultant to handle the company’s negotiations with the FDA.

BrainStorm president Chaim Lebovits said, "BrainStorm’s preclinical research related to Parkinson's disease has reached the stage where we are ready to approach the FDA about initiating clinical Phase I trials.

Source Publication: GLOBES [online]
View source URL


built@zoomedia